Cite
APA Citation
Shinde, A., Horne, Z. D., Li, R., Glaser, S., Massarelli, E., Koczywas, M., Erhunmwunsee, L., Reckamp, K. L., Weksler, B., Salgia, R., Beriwal, S., & Amini, A. (2019). optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio. Lung cancer, 133, 136–143. http://access.bl.uk/ark:/81055/vdc_100085410148.0x000052